Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial

Rationale: Oral treprostinil improves exercise capacity in patients with pulmonary arterial hypertension (PAH), but the effect on clinical outcomes was unknown. Objectives: To evaluate the effect of oral treprostinil compared with placebo on time to first adjudicated clinical worsening event in part...

Descripción completa

Detalles Bibliográficos
Autores principales: White, R. James, Jerjes-Sanchez, Carlos, Bohns Meyer, Gisela Martina, Pulido, Tomas, Sepulveda, Pablo, Wang, Kuo Yang, Grünig, Ekkehard, Hiremath, Shirish, Yu, Zaixin, Gangcheng, Zhang, Yip, Wei Luen James, Zhang, Shuyang, Khan, Akram, Deng, C. Q., Grover, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068822/
https://www.ncbi.nlm.nih.gov/pubmed/31765604
http://dx.doi.org/10.1164/rccm.201908-1640OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068822/
https://www.ncbi.nlm.nih.gov/pubmed/31765604
http://dx.doi.org/10.1164/rccm.201908-1640OC

Ejemplares similares